ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
University of Washington
Seattle, Estados UnidosUniversity of Washington-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Clinical Cancer Research, Vol. 28, Núm. 16, pp. 3452-3463